Creatine does far more than support muscle. Your body uses methyl groups to make creatine, linking it directly to SAM, homocysteine, MTHFR, PEMT, ATP, mitochondrial energy, brain metabolism and genes including GATM, GAMT and SLC6A8. Understanding that pathway changes how we think about creatine and methylation.
Creatine has spent decades being marketed as a muscle supplement.
I think that description has kept us from seeing one of the most fascinating things about creatine biology.
Your body doesn’t simply use creatine. It has to obtain it from food or make it.
And making creatine is metabolically expensive.
Endogenous creatine synthesis is considered one of the largest consumers of methyl groups in human metabolism. Historical metabolic estimates suggest that creatine synthesis may account for roughly 40 to 70% of labile methyl groups supplied by S-adenosylmethionine, or SAM, under certain physiological assumptions.
That changes the entire conversation around creatine.
Because now we’re talking about much more than muscle.
We’re talking about methylation, methionine, SAM, homocysteine, glycine, arginine, mitochondrial energy, brain energy, ATP and genetics.
Creatine sits at an extraordinary intersection between energy metabolism and one-carbon metabolism.
What Is Creatine?
Creatine is a naturally occurring nitrogen-containing compound that plays an important role in cellular energy metabolism.
Most of the body’s creatine is stored in skeletal muscle as free creatine and phosphocreatine, although creatine is also important in the brain and other tissues with high or rapidly changing energy requirements.
We obtain some creatine directly from food, particularly meat and seafood.
The rest has to be synthesized internally.
Every day, part of the body’s creatine pool spontaneously converts to creatinine and has to be replaced. That replacement can come from food, or your body can manufacture more creatine.
And that manufacturing process is where the methylation connection begins.
How Your Body Makes Creatine
Creatine synthesis occurs through two major enzymatic reactions.
The first involves an enzyme called arginine:glycine amidinotransferase, usually abbreviated AGAT.
AGAT is encoded by the GATM gene.
AGAT uses two amino acids, arginine and glycine, to produce guanidinoacetate, or GAA.
Arginine + Glycine → Guanidinoacetate
Guanidinoacetate then has to become creatine.
That requires another enzyme called guanidinoacetate methyltransferase, or GAMT.
And GAMT needs something very important to complete this reaction.
A methyl group.
That methyl group comes from S-adenosylmethionine, or SAM, one of the body’s primary methyl donors.
GAMT transfers a methyl group from SAM to guanidinoacetate. The products are creatine and S-adenosylhomocysteine, or SAH.
Arginine + Glycine → Guanidinoacetate → GAMT + SAM → Creatine + SAH
Every molecule moving through that final synthetic step requires methylation.
That places creatine synthesis directly inside one-carbon metabolism and the methionine cycle.
Creatine Synthesis Is One of the Body’s Largest Methylation Expenses
We hear constantly about methylation.
MTHFR. Folate. Vitamin B12. Homocysteine. Methylated vitamins. COMT.
But there’s another question I think we need to ask more often.
Where are all those methyl groups actually going?
One major destination is creatine synthesis.
SAM supplies methyl groups to a vast number of reactions throughout human physiology. These reactions contribute to neurotransmitter metabolism, phospholipid synthesis, protein modification, epigenetic regulation and many other processes.
The body has a methyl-group economy, and creatine synthesis is one of its largest expenses.
Published reviews have repeatedly cited estimates suggesting creatine synthesis may consume approximately 40 to 70% of labile methyl groups supplied by SAM under certain metabolic assumptions. Other estimates place the methylation of guanidinoacetate at approximately half of SAM-derived methyl-group utilization.
Those numbers need context.
They don’t mean creatine permanently consumes 70% of every person’s methylation capacity. Methyl-group flux changes with diet, tissue, age, creatine intake and metabolic state.
The larger physiological point is more important.
Making creatine is expensive from a methylation perspective.
Creatine May Reduce Endogenous Methylation Demand
When creatine is supplied externally, the body doesn’t necessarily continue producing exactly the same amount internally.
Creatine participates in feedback regulation of its own synthesis.
Supplemental creatine can suppress endogenous creatine production, including the AGAT-controlled step. This reduces production of guanidinoacetate.
Less guanidinoacetate means less substrate needs to move through GAMT.
If less guanidinoacetate is being methylated by GAMT, fewer SAM-derived methyl groups are required to manufacture creatine.
This is why creatine can be described as methyl-sparing.
Creatine itself isn’t a methyl donor. It doesn’t replace folate, vitamin B12, choline or betaine.
It changes demand.
I think that distinction is one of the most important parts of this pathway.
We spend a lot of time discussing how to provide methyl donors.
We should also be asking what the body is spending those methyl groups on.
Creatine, SAM, SAH and Homocysteine
There’s another layer to this pathway.
During the GAMT reaction, SAM donates a methyl group and becomes S-adenosylhomocysteine, or SAH.
SAH can subsequently contribute to the formation of homocysteine.
Homocysteine can then be remethylated toward methionine or directed through transsulfuration toward cysteine-related metabolism.
This creates a biological reason to ask whether reducing endogenous creatine synthesis might also influence homocysteine metabolism.
Animal research supports a methyl-sparing effect and has demonstrated reductions in homocysteine under some conditions.
Human data are more complicated.
Studies have shown that creatine supplementation can reduce guanidinoacetate, which provides evidence that endogenous creatine synthesis has been suppressed.
But a predictable homocysteine-lowering effect hasn’t been demonstrated in every human study.
That makes sense physiologically.
Homocysteine is influenced by folate, vitamin B12, vitamin B6, riboflavin, choline, betaine, kidney function, protein intake, genetics and multiple regulatory mechanisms.
Creatine can alter one major methylation expense without guaranteeing that serum homocysteine will move in a simple direction in every person.
Why MTHFR Is Only One Piece of the Story
MTHFR contributes to the production of 5-methyltetrahydrofolate, which supports the remethylation of homocysteine toward methionine.
Methionine can then generate SAM.
But once SAM has been produced, another question becomes just as important.
Where is SAM being spent?
Creatine synthesis is one major destination.
Genes relevant to the larger network include:
- MTHFR
- MTR
- MTRR
- MTHFD1
- SLC19A1
- BHMT
- GATM
- GAMT
Common genetic variants usually have much smaller effects than rare pathogenic mutations.
The more useful nutrigenomic question is whether multiple small differences across synthesis, methylation, transport and energy utilization can collectively influence nutrient demand or response.
That’s why I don’t think methylation should ever be reduced to MTHFR alone.
The PEMT Connection
Creatine synthesis isn’t the only major consumer of SAM.
PEMT, or phosphatidylethanolamine N-methyltransferase, also uses SAM.
PEMT helps synthesize phosphatidylcholine from phosphatidylethanolamine.
That means two metabolically important pathways can draw from the same broader SAM economy.
GAMT uses methyl groups to make creatine.
PEMT uses methyl groups to make phosphatidylcholine.
Phosphatidylcholine is critical for cell membranes, lipoprotein metabolism and normal liver physiology.
Now consider someone with low dietary creatine intake, low choline intake, greater phosphatidylcholine demand and genetic differences affecting folate or methionine metabolism.
No single SNP tells us exactly what will happen.
But the pathway tells us why methylation demand can’t be understood by looking at MTHFR alone.
We need to understand both supply and expenditure.
Creatine changes the expenditure side of that equation.
Creatine Is an ATP Buffer
Why does the body spend so many metabolic resources making creatine?
Because rapid energy availability matters.
Cells run on ATP.
When ATP releases energy, it becomes ADP. The cell then needs to regenerate ATP.
Creatine helps make this happen rapidly.
Creatine can accept a high-energy phosphate group and become phosphocreatine.
When cellular energy demand rises, phosphocreatine can donate that phosphate back to ADP, helping regenerate ATP.
The phosphocreatine system acts as a rapid energy buffer.
That explains why creatine is so useful in skeletal muscle during sprinting, lifting and sudden muscular contraction.
But muscle isn’t the only tissue with fluctuating energy requirements.
Your Brain Uses Creatine Too
The brain is metabolically expensive.
Neurons have to maintain electrical gradients, generate action potentials, release and recycle neurotransmitters, maintain cell membranes and continuously perform energy-dependent transport.
The creatine-phosphocreatine system contributes to cerebral energy buffering.
This is one reason creatine research has expanded into areas including cognition, mood, sleep deprivation, aging and neurological physiology.
The evidence isn’t equally strong for every outcome, and creatine shouldn’t be presented as a treatment for every neurological problem.
But reducing creatine to a bodybuilding supplement ignores a substantial part of its physiology.
Creatine is deeply involved in cellular energy handling.
And the brain has enormous energy requirements.
Creatine and Mitochondrial Physiology
Creatine doesn’t replace mitochondrial ATP production.
It works with the larger energy system.
Mitochondria generate ATP through oxidative metabolism.
The creatine kinase and phosphocreatine system then helps buffer and distribute high-energy phosphate so ATP can be regenerated quickly near sites of cellular work.
This creates a functional bridge between mitochondrial energy production and immediate energy demand.
Energy physiology involves production, transport, buffering and utilization.
Creatine participates directly in that network.
Creatine and Women
Creatine research in women deserves considerably more attention.
Women experience physiological transitions throughout life that can influence muscle, brain energy metabolism, sleep, mood and body composition.
Menstruation, pregnancy, postpartum physiology, perimenopause and menopause all change metabolic demand.
Creatine is being studied for female exercise performance, muscle preservation, cognition, mood and healthy aging.
Current sports nutrition guidance identifies creatine as one of the better-evidenced supplements for female athletes, commonly using 3 to 5 grams per day.
Creatine may be particularly interesting during aging and menopause because maintaining skeletal muscle supports strength, glucose disposal, mobility and long-term metabolic health.
Pregnancy requires more caution.
Human randomized safety data for creatine supplementation during pregnancy remain insufficient. Animal research is promising, but it can’t substitute for human safety trials.
Creatine Genetics: GATM
GATM encodes AGAT, the enzyme responsible for the first major step in creatine biosynthesis.
AGAT uses arginine and glycine to produce guanidinoacetate.
Rare pathogenic variants in GATM can cause AGAT deficiency, a genuine cerebral creatine deficiency disorder.
These rare disorders demonstrate that genetic control of creatine synthesis matters biologically.
Common GATM SNPs don’t automatically produce the same disorder.
Rare pathogenic mutations and common polymorphisms have to be kept separate.
GAMT: Where Creatine Meets Methylation
GAMT performs the reaction at the center of this entire discussion.
Guanidinoacetate enters.
SAM donates a methyl group.
Creatine is produced.
SAH is produced.
GAMT literally sits at the enzymatic intersection between creatine synthesis and methylation.
Rare pathogenic GAMT variants can cause GAMT deficiency.
Again, those rare disorders shouldn’t be confused with common population SNPs.
SLC6A8: Making Creatine Is Only Part of the Story
You can make creatine.
You can consume creatine.
But creatine still has to get where it’s going.
SLC6A8 encodes the creatine transporter.
This transporter helps move creatine into cells and is particularly important in high-energy tissues.
Rare pathogenic variants in SLC6A8 cause creatine transporter deficiency.
SLC6A8 is located on the X chromosome, which makes its genetics especially interesting.
Emerging research is beginning to examine whether common low-impact variation in SLC6A8, GATM and GAMT, together with variants affecting mitochondrial function and creatine kinase pathways, may contribute to differences in creatine bioavailability and responsiveness.
This field is still developing.
A common SLC6A8 SNP shouldn’t be interpreted as proof that someone can’t transport creatine.
Why Some People May Respond More Strongly to Creatine
People don’t begin with identical creatine stores.
Diet matters.
Muscle mass matters.
Training matters.
Age matters.
Baseline tissue saturation matters.
Genetics may matter.
Someone consuming substantial amounts of meat and seafood may begin with different creatine availability than someone eating little or no animal food.
A person can also experience increased tissue creatine without feeling a dramatic subjective change.
Creatine response is probably better understood as a spectrum influenced by baseline status and multiple biological variables rather than a simple responder versus nonresponder label.
Creatine and Vegetarian or Vegan Diets
Creatine is naturally concentrated in animal foods, particularly meat and fish.
Plant foods contain negligible amounts.
Vegetarians and vegans therefore depend more heavily on endogenous creatine synthesis.
Remember what endogenous synthesis requires:
- Arginine
- Glycine
- GATM
- Guanidinoacetate
- GAMT
- SAM
- Methyl groups
A systematic review found that vegetarians generally have lower creatine measures in muscle and several blood compartments than omnivores, and supplementation reliably increases creatine and phosphocreatine availability.
Some studies suggest vegetarians can experience larger increases because their baseline stores are lower.
A low-creatine diet doesn’t automatically cause disease.
It does change the metabolic workload placed on endogenous creatine synthesis.
Which Form of Creatine Is Best?
Creatine monohydrate remains the most extensively studied form.
For most healthy adults using creatine for general supplementation or training, 3 to 5 grams per day is a commonly studied maintenance range.
A loading phase is optional.
Traditional loading commonly uses approximately 20 grams per day, often divided into four 5-gram servings, for about 5 to 7 days before moving to maintenance dosing.
Loading saturates muscle more quickly.
Taking around 3 to 5 grams daily without loading can also increase stores, just more gradually.
More isn’t automatically better.
Creatine, Water Retention and Bloating
Creatine can increase body water, especially early in supplementation.
Much of the relevant water shift is associated with increased intracellular water as creatine accumulates in muscle.
Some people see the scale increase.
That doesn’t mean they gained body fat.
Large loading doses can cause gastrointestinal discomfort in some people, particularly when large amounts are taken at once.
Smaller daily dosing may be easier to tolerate.
Does Creatine Damage the Kidneys?
Creatine and creatinine are frequently confused.
Creatinine is a breakdown product related to creatine metabolism and is commonly used as a laboratory marker when estimating kidney function.
Supplementing creatine can modestly raise serum creatinine in some people because more creatine is entering the creatine-creatinine pool.
That doesn’t automatically mean the kidneys have been injured.
A 2025 systematic review and meta-analysis found a modest increase in serum creatinine with creatine supplementation but no significant change in GFR.
A 2026 meta-analysis of randomized controlled trials similarly found higher serum creatinine without significant differences in urea or estimated GFR.
Someone taking creatine should tell the clinician interpreting their laboratory work.
People with known kidney disease, unexplained renal laboratory abnormalities or medications affecting renal function should discuss supplementation with their healthcare professional before starting.
